Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma

Cisplatin is one of the most potent chemotherapy drugs widely used for cancer treatment. However, due to resistance and toxicity, the application of cisplatin for the treatment of hepatocellular carcinoma (HCC) is limited. Our previous study has shown that granulin A (GRN A), an anticancer peptide,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Gan, Xu, Huanli, Li, Cong, Li, Xiao, Farooqi, Ammad Ahmad, Zhao, Yuming, Liu, Xiaohui, Liu, Ming, Stagos, Dimitrios, Lin, Xiukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213591/
https://www.ncbi.nlm.nih.gov/pubmed/30301274
http://dx.doi.org/10.3390/ijms19103060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213591/
https://www.ncbi.nlm.nih.gov/pubmed/30301274
http://dx.doi.org/10.3390/ijms19103060

Ejemplares similares